IGM Biosciences, Inc. Marketable Securities
IGM Biosciences, Inc. had Marketable Securities of $73.66 million as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2025-07-31
- 2025-06-30: Marketable Securities $73.66M.
- 2025-03-31: Marketable Securities $115.23M.
- 2024-12-31: Marketable Securities $157.29M.
- 2024-09-30: Marketable Securities $175.91M.
| Period end | Marketable Securities |
|---|---|
| 2025-06-30 | $73.66M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $115.23M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $157.29M 10-Q · filed 2025-07-31 |
| 2024-09-30 | $175.91M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $189.41M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $214.59M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $225.16M 10-K · filed 2025-03-06 |
| 2023-09-30 | $212.20M 10-Q · filed 2023-11-13 |
| 2022-12-31 | $305.93M 10-K · filed 2024-03-07 |